• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term continuous terlipressin infusion in cirrhotic patients with hepatorenal syndrome or refractory ascites awaiting liver transplantation is associated with an increase in plasma sodium.

作者信息

McClure T, Chapman B, Hey P, Testro A, Gow P

机构信息

Liver Transplant Unit, Austin Hospital, Melbourne, Australia.

Department of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia.

出版信息

United European Gastroenterol J. 2019 Nov;7(9):1271-1273. doi: 10.1177/2050640619878996. Epub 2019 Sep 19.

DOI:10.1177/2050640619878996
PMID:31700640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6826519/
Abstract
摘要

相似文献

1
Long-term continuous terlipressin infusion in cirrhotic patients with hepatorenal syndrome or refractory ascites awaiting liver transplantation is associated with an increase in plasma sodium.对于患有肝肾综合征或难治性腹水且正在等待肝移植的肝硬化患者，长期持续输注特利加压素与血浆钠升高有关。
United European Gastroenterol J. 2019 Nov;7(9):1271-1273. doi: 10.1177/2050640619878996. Epub 2019 Sep 19.
2
Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant.持续输注特利加压素与等待肝移植患者的饮食摄入量改善和肌肉力量增强有关。
JHEP Rep. 2019 May 17;1(2):107-113. doi: 10.1016/j.jhepr.2019.05.002. eCollection 2019 Aug.
3
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.2型肝肾综合征与顽固性腹水：经颈静脉肝内门体分流术在18例等待原位肝移植的晚期肝硬化患者中的作用
Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.
4
Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.特利加压素在肝硬化伴腹水且无肝肾综合征患者中的作用：当前证据的系统评价。
Can J Gastroenterol Hepatol. 2020 Jun 22;2020:5106958. doi: 10.1155/2020/5106958. eCollection 2020.
5
The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.特利加压素在肝硬化伴难治性腹水且肾功能正常患者中的应用：一项多中心研究。
Eur J Intern Med. 2011 Dec;22(6):587-90. doi: 10.1016/j.ejim.2011.06.013. Epub 2011 Aug 2.
6
[Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].特利加压素治疗肝硬化腹水相关并发症的研究进展
Zhonghua Gan Zang Bing Za Zhi. 2019 Dec 20;27(12):929-932. doi: 10.3760/cma.j.issn.1007-3418.2019.12.005.
7
Duodenal Necrosis and Nonvariceal Digestive Bleeding After Terlipressin Administration for Treatment of Hepatorenal Syndrome: a Case Report of a Novel Side Effect of a Commonly Used Drug.特利加压素治疗肝肾综合征后发生十二指肠坏死和非静脉曲张性消化道出血：一种常用药物的新的副作用的病例报告。
Transplant Proc. 2022 Jun;54(5):1391-1393. doi: 10.1016/j.transproceed.2022.03.023. Epub 2022 Jun 5.
8
Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.长期使用特利加压素可改善1型肝肾综合征肝硬化患者的肾功能：一项初步研究。
Acta Gastroenterol Belg. 2001 Jan-Mar;64(1):15-9.
9
Hepatorenal syndrome: Current concepts related to diagnosis and management.肝肾综合征：与诊断和管理相关的当前概念
Ann Hepatol. 2016 Jul-Aug;15(4):474-81.
10
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.特利加压素可改善肝硬化腹水且无肝肾综合征患者的肾功能。
Hepatology. 2007 Dec;46(6):1863-71. doi: 10.1002/hep.21901.

引用本文的文献

1
The current applications and future directions of terlipressin.特利加压素的当前应用及未来方向。
Hepatol Commun. 2025 Apr 3;9(4). doi: 10.1097/HC9.0000000000000685. eCollection 2025 Apr 1.
2
From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury.从过去到现在再到未来：特利加压素与肝肾综合征 - 急性肾损伤
Hepatology. 2025 Jun 1;81(6):1878-1897. doi: 10.1097/HEP.0000000000000790. Epub 2024 Feb 14.
3
HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan.HEP-Net关于在巴基斯坦资源有限环境下失代偿期肝硬化患者腹水及其并发症管理的意见。
Pak J Med Sci. 2020 Jul-Aug;36(5):1117-1132. doi: 10.12669/pjms.36.5.2407.

本文引用的文献

1
Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant.持续输注特利加压素与等待肝移植患者的饮食摄入量改善和肌肉力量增强有关。
JHEP Rep. 2019 May 17;1(2):107-113. doi: 10.1016/j.jhepr.2019.05.002. eCollection 2019 Aug.
2
Terlipressin for variceal bleeding induces large plasma sodium fluctuations in patients without cirrhosis.特利加压素治疗静脉曲张出血会在无肝硬化患者中引起血浆钠大幅波动。
United European Gastroenterol J. 2018 Oct;6(8):1199-1205. doi: 10.1177/2050640618781205. Epub 2018 May 28.
3
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.特利加压素与安慰剂或不干预措施治疗肝硬化和肝肾综合征患者的比较
Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD005162. doi: 10.1002/14651858.CD005162.pub4.
4
Terlipressin: Current and emerging indications in chronic liver disease.特利加压素：慢性肝脏疾病中的现有和新兴适应证。
J Gastroenterol Hepatol. 2018 Mar;33(3):591-598. doi: 10.1111/jgh.14009.
5
Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.特利加压素持续静脉输注与静脉推注治疗肝肾综合征的随机对照研究。
Hepatology. 2016 Mar;63(3):983-92. doi: 10.1002/hep.28396. Epub 2016 Feb 3.
6
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.肝硬化患者急性肾损伤的诊断与管理：国际腹水俱乐部修订的共识建议
J Hepatol. 2015 Apr;62(4):968-74. doi: 10.1016/j.jhep.2014.12.029. Epub 2015 Jan 28.
7
Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure.特利加压素治疗肝衰竭患者中至重度低钠血症。
Intern Med J. 2013 Mar;43(3):240-6. doi: 10.1111/imj.12032.
8
Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects.特利加压素对水利尿系统的影响：抗利尿作用的证据。
Am J Physiol Renal Physiol. 2008 Nov;295(5):F1295-300. doi: 10.1152/ajprenal.90407.2008. Epub 2008 Aug 27.